Metropolitan Life Insurance Company (MetLife)’s Revvity RVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,976
| Closed | -$522K | – | 1712 |
|
|
2024
Q1 | $522K | Sell |
4,976
-46
| -0.9% | -$4.89K | 0.02% | 467 |
|
|
2023
Q4 | $549K | Sell |
5,022
-113
| -2% | -$10.9K | 0.03% | 448 |
|
|
2023
Q3 | $568K | Sell |
5,135
-331
| -6% | -$38.9K | 0.03% | 419 |
|
|
2023
Q2 | $649K | Sell |
5,466
-183
| -3% | -$22.5K | 0.03% | 408 |
|
|
2023
Q1 | $753K | Sell |
5,649
-1,650
| -23% | -$217K | 0.04% | 382 |
|
|
2022
Q4 | $1.02M | Buy |
7,299
+52
| +0.7% | +$7K | 0.05% | 364 |
|
|
2022
Q3 | $872K | Sell |
7,247
-85
| -1% | -$12K | 0.04% | 382 |
|
|
2022
Q2 | $1.04M | Sell |
7,332
-191
| -3% | -$28.6K | 0.05% | 356 |
|
|
2022
Q1 | $1.31M | Sell |
7,523
-6,635
| -47% | -$1.18M | 0.05% | 348 |
|
|
2021
Q4 | $2.85M | Buy |
14,158
+1,220
| +9% | +$221K | 0.04% | 381 |
|
|
2021
Q3 | $2.24M | Sell |
12,938
-445
| -3% | -$78.4K | 0.03% | 455 |
|
|
2021
Q2 | $2.07M | Sell |
13,383
-1,295
| -9% | -$182K | 0.03% | 514 |
|
|
2021
Q1 | $1.88M | Sell |
14,678
-755
| -5% | -$105K | 0.03% | 548 |
|
|
2020
Q4 | $2.21M | Sell |
15,433
-861
| -5% | -$115K | 0.03% | 439 |
|
|
2020
Q3 | $2.05M | Sell |
16,294
-660
| -4% | -$75.9K | 0.03% | 408 |
|
|
2020
Q2 | $1.66M | Sell |
16,954
-762
| -4% | -$69.7K | 0.03% | 472 |
|
|
2020
Q1 | $1.33M | Sell |
17,716
-119
| -0.7% | -$10.6K | 0.03% | 545 |
|
|
2019
Q4 | $1.73M | Sell |
17,835
-8
| -0% | -$714 | 0.03% | 613 |
|
|
2019
Q3 | $1.52M | Buy |
17,843
+1,279
| +8% | +$112K | 0.03% | 639 |
|
|
2019
Q2 | $1.6M | Buy |
16,564
+1,199
| +8% | +$112K | 0.03% | 633 |
|
|
2019
Q1 | $1.48M | Sell |
15,365
-604
| -4% | -$54.4K | 0.03% | 647 |
|
|
2018
Q4 | $1.25M | Buy |
15,969
+36
| +0.2% | +$3.04K | 0.03% | 673 |
|
|
2018
Q3 | $1.55M | Sell |
15,933
-592
| -4% | -$50.9K | 0.03% | 672 |
|
|
2018
Q2 | $1.21M | Sell |
16,525
-1,419
| -8% | -$106K | 0.02% | 823 |
|
|
2018
Q1 | $1.36M | Buy |
17,944
+139
| +0.8% | +$10.7K | 0.02% | 747 |
|
|
2017
Q4 | $1.3M | Sell |
17,805
-35,447
| -67% | -$2.54M | 0.02% | 777 |
|
|
2017
Q3 | $3.67M | Sell |
53,252
-1,006
| -2% | -$67.5K | 0.02% | 736 |
|
|
2017
Q2 | $3.7M | Sell |
54,258
-1,267
| -2% | -$78.7K | 0.03% | 725 |
|
|
2017
Q1 | $3.22M | Sell |
55,525
-732
| -1% | -$39.9K | 0.02% | 795 |
|
|
2016
Q4 | $2.93M | Sell |
56,257
-750
| -1% | -$39.2K | 0.02% | 824 |
|
|
2016
Q3 | $3.2M | Sell |
57,007
-299
| -0.5% | -$16.3K | 0.02% | 766 |
|
|
2016
Q2 | $3M | Sell |
57,306
-834
| -1% | -$43.8K | 0.02% | 772 |
|
|
2016
Q1 | $2.88M | Sell |
58,140
-1,911
| -3% | -$91.3K | 0.02% | 767 |
|
|
2015
Q4 | $3.22M | Sell |
60,051
-2,140
| -3% | -$109K | 0.02% | 698 |
|
|
2015
Q3 | $2.86M | Sell |
62,191
-1,031
| -2% | -$51.2K | 0.02% | 758 |
|
|
2015
Q2 | $3.33M | Sell |
63,222
-172
| -0.3% | -$8.97K | 0.02% | 746 |
|
|
2015
Q1 | $3.24M | Sell |
63,394
-794
| -1% | -$36.8K | 0.02% | 712 |
|
|
2014
Q4 | $2.81M | Sell |
64,188
-511
| -0.8% | -$22K | 0.02% | 818 |
|
|
2014
Q3 | $2.82M | Sell |
64,699
-1,134
| -2% | -$51.6K | 0.02% | 789 |
|
|
2014
Q2 | $3.08M | Sell |
65,833
-2,087
| -3% | -$93.7K | 0.02% | 788 |
|
|
2014
Q1 | $3.06M | Sell |
67,920
-812
| -1% | -$35.6K | 0.02% | 775 |
|
|
2013
Q4 | $2.83M | Sell |
68,732
-394
| -0.6% | -$15.1K | 0.02% | 793 |
|
|
2013
Q3 | $2.61M | Sell |
69,126
-325
| -0.5% | -$11.7K | 0.02% | 793 |
|
|
2013
Q2 | $2.26M | Buy |
+69,451
| New | +$2.27M | 0.02% | 820 |
|
Other funds holding RVTY
Metropolitan Life Insurance Company (MetLife)'s RVTY Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Revvity (RVTY) in Q2 2024, closing a stake of 4,976 shares — an estimated $522K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in RVTY in Q2 2013 and held it in 44 quarters. The position peaked at $3.7M in Q2 2017. 484 funds tracked by Wall St. Rank hold RVTY as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Revvity position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 4,976 Revvity shares in Q2 2024, an estimated $522K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Revvity in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Revvity position peaked at $3.7M in Q2 2017.
- 484 funds tracked by Wall St. Rank held Revvity as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.